Valuation: AstraZeneca PLC

Market Cap 248B 215B 201B 184B 346B 23,670B 352B 2,361B 925B 11,847B 932B 911B 39,525B P/E 2026 *
20.5x
P/E 2027 * 17.9x
Enterprise Value 267B 232B 217B 198B 373B 25,513B 379B 2,545B 997B 12,770B 1,004B 982B 42,603B EV / Sales 2026 *
4.23x
EV / Sales 2027 * 3.89x
Free-Float
96.63%
Yield 2026 *
2.08%
Yield 2027 * 2.2%
1 day-1.22%
1 week+0.89%
Current month-6.24%
1 month-7.71%
3 months-12.28%
6 months-20.07%
Current year-14.11%
1 week 11,818
Extreme 11818
12,172
1 month 10,524
Extreme 10524
13,164
Current year 10,524
Extreme 10524
15,732
1 year 10,524
Extreme 10524
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
8/6/26 Free

SVP, Group Controller

2 0.0000%
7/6/26 Free

See Remarks

2 0.0000%
12/22/25 Sell

Director

297 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%+0.89%+7.32%+7.38% 251B
-1.37%+8.90%+91.28%+130.00% 1,098B
-0.77%+1.91%+49.46%+49.44% 631B
+0.85%+2.58%+25.90%+64.34% 438B
-1.13%+3.13%+49.78%+39.13% 368B
-0.74%+1.01%+31.08%+38.64% 298B
-0.70%+6.23%+45.32%+57.82% 226B
+0.34%-0.13%-4.77%-50.50% 209B
+2.04%+0.38%+12.70%+69.71% 165B
-1.59%+4.76%+8.30%-26.14% 154B
Average -0.24%+1,498.95%+31.64%+37.98% 383.85B
Weighted average by Cap. -0.59%+1,286.79%+48.15%+62.49%

Financials

2026 *2027 *
Net sales 63.25B 54.81B 51.31B 46.82B 88.11B 6,033B 89.59B 602B 236B 3,020B 237B 232B 10,074B 66.85B 57.94B 54.24B 49.49B 93.13B 6,376B 94.69B 636B 249B 3,192B 251B 246B 10,648B
Net income 12.07B 10.46B 9.79B 8.93B 16.81B 1,151B 17.1B 115B 44.99B 576B 45.32B 44.33B 1,922B 13.72B 11.89B 11.13B 10.15B 19.11B 1,308B 19.43B 130B 51.12B 655B 51.5B 50.38B 2,184B
Net Debt 19.33B 16.75B 15.68B 14.31B 26.92B 1,843B 27.37B 184B 72.03B 923B 72.56B 70.98B 3,078B 11.66B 10.1B 9.46B 8.63B 16.24B 1,112B 16.51B 111B 43.45B 557B 43.77B 42.82B 1,857B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-08-11 GBX 11,844.00 -1.22% 2,713,440
26-08-10 GBX 11,990.00 +0.79% 3,827,803
26-08-07 GBX 11,896.00 +0.39% 12,677,979
26-08-06 GBX 11,850.00 -1.55% 2,357,103
26-08-05 GBX 12,036.00 +2.52% 6,337,651
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
160.00USD
Average target price
211.65USD
Spread / Average Target
+32.28%

Quarterly revenue - Rate of surprise